Xencor Inc share price logo

Xencor Inc Share Price

NASDAQ: XNCR

Small Cap

$11.44

-0.87

(-7.07%)

as on

Xencor Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $11.27
    $12.40
    downward going graph

    1.49%

    Downside

    8.39%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.92
    $18.69
    downward going graph

    39.51%

    Downside

    63.37%

    Upside

    downward going graph

Xencor Inc share price movements today

Previous Close
$12.31
Open
$12.17
Volume
772.1K
Day's Low - High
$11.27 - $12.40
52 Week Low - High
$6.92 - $18.69

Xencor Inc Historical Returns

1 Month Return
-7.15 %
3 Month Return
-24.02 %
1 Year Return
+ 1.69 %
3 Year Return
-58.32 %
5 Year Return
-72.02 %

Xencor Inc Stock Fundamentals & Key Indicators

Check Xencor Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$837.5M

EPS (TTM)

-3.0783

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6

Industry PE ratio

-4.138122977346279

PEG Ratio

0

EBITDA

-167.0M

Revenue (TTM)

125.6M

Profit Margin

-73.20%

Return On Equity TTM

-14.07%

Xencor Inc Stock Valuation

Track how Xencor Inc P/E has moved over time to understand its valuation trends.

Xencor Inc in the last 5 years

  • Overview

  • Trends

Lowest (-42.68x)

March 31, 2021

Today (-6.00x)

March 30, 2026

Industry (-4.14x)

March 30, 2026

Highest (107.15x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -6.00x

Xencor Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xencor Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Xencor Inc image
Xencor Inc
BUY$837.5M-72.02%-6-73.20%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.1B134.86%136.798.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.0B103.33%28.2532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA115.055.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B56.74%17.7931.41%

Stock Returns calculator for Xencor Inc Stock including INR - Dollar returns

The Xencor Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xencor Inc investment value today

Current value as on today

₹1,12,801

Returns

₹12,801

(+12.8%)

Returns from Xencor Inc Stock

₹1,870 (+1.87%)

Dollar Impact

₹10,931 (+10.93%)

Analyst Recommendation on Xencor Inc Stock

Based on 19 analysts

BUY

84.21%

Buy

10.53%

Hold

5.26%

Sell

Based on 19 analysts, 84.21% of analysts recommend a 'BUY' rating for Xencor Inc. Average target price of $28.42

Xencor Inc Share Price Target

Get share price movements and forecasts by analysts on Xencor Inc.

What analysts predicted

59.75%UPSIDE

Target Price

$28.42

Current Price

$11.44

Analyzed by

19 Analysts

Target

$28.42

Xencor Inc target price $28.42, a slight upside of 59.75% compared to current price of $11.44. According to 19 analysts rating.

Xencor Inc Stock’s Investor Sentiment and Interest

Search interest for Xencor Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Xencor Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
59
50
15
16
17
70
32
43
20
28
Gross Profit
-5
47
15
13
17
70
30
40
20
25
Operating Income
-18
-28
-54
-62
-55
4
-43
-33
-47
-53
EBITDA
-15
-3
-61
-63
-35
-15
-36
-20
4
5
Interest Expense
0
6
9
0
0
33
8
8
7
7
Depreciation
3
3
3
3
3
2
2
2
2
2
Income Before Tax
-24
-12
-74
-67
-47
-52
-48
-31
-6
-4
Income Tax Expense
-3
13
0
0
-1
1
0
0
-
2
Net Income
-24
-26
-73
-65
-46
-53
-48
-30
-6
-6
Net Profit Margin
-41.02%
-51.30%
-459.09%
-388.93%
-260.10%
-76.38%
-147.92%
-70.69%
-28.70%
-23.56%

Xencor Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
87
35
40
156
122
275
164
168
110
125
Gross Profit
87
35
40
38
122
275
164
-85
110
115
Operating Income
22
-53
-79
13
-76
43
-82
-138
-178
-177
EBITDA
24
-51
-76
18
-71
51
-73
-125
-186
-46
Interest Expense
0
0
0
17
-
7
36
6
36
31
Depreciation
-
2
3
4
5
7
8
10
12
10
Income Before Tax
24
-49
-70
27
-69
82
-54
-120
-234
-89
Income Tax Expense
0
0
8
0
-5
-7
0
5
1
2
Net Income
23
-48
-70
26
-63
82
-55
-126
-232
-91
Net Profit Margin
26.99%
-137.00%
-173.41%
17.15%
-51.79%
30.04%
-33.53%
-74.90%
-210.53%
-73.20%

Xencor Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-26
-68
-68
-48
-54
-48
-30
-6
85
Operating Cash Flow
18
-55
-67
-26
-55
-16
-36
-30
-51
Investing Cash Flow
-202
32
66
-163
57
11
40
14
71
Financing Cash Flow
185
0
1
187
10
2
0
-
6
Change in Cash
1
-22
0
-1
11
-1
4
-16
25

Xencor Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-48
-70
26
-69
82
-55
-126
-236
-91
Operating Cash Flow
-33
-79
64
-5
-16
24
85
-202
-135
Investing Cash Flow
31
-164
-50
100
-46
-119
-
-7
139
Financing Cash Flow
3
254
10
18
43
5
26
197
8
Change in Cash
2
9
24
113
-20
-89
0
-12
13

Global Institutional Holdings in Xencor Inc

Funds
Holdings
TCG Crossover Management, LLC
3.34%
Johnson & Johnson
1.02%
PRIMECAP Management Company
13.93%
Geode Capital Management, LLC
2.36%
State Street Corp
5.01%
See all

Insights on Xencor Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 20.99M → 28.23M (in $), with an average increase of 25.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.6% return, outperforming this stock by 120.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 16.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, XNCR stock has moved down by -5.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -6.02M → -6.65M (in $), with an average decrease of 10.4% per quarter

About Xencor Inc

antibodies by design antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. at xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics – antibodies that target new biological mechanisms and are more potent, safer and longer lasting – to improve patient outcomes and quality of life. our xmab antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. this combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance. the xmab® platform has resulted in a robust pipeline of antibody product candidates, including eight in human clinical trials being developed by xencor and by pharmaceutical partners. xencor is also discovering biologics product
OrganisationXencor Inc
Headquarters465 North Halstead Street, Pasadena, CA, United States, 91107
IndustryHealth Technology
CEODr. Bassil I. Dahiyat Ph.D.
E-voting on sharesClick here to vote

Key Management of Xencor Inc

Name

Title

Ms. Jennifer Sandoz

Senior VIce President of Human Resources

Mr. Dane Vincent Leone C.F.A.

Executive VP & Chief Strategy Officer

Dr. John R. Desjarlais Ph.D.

Executive VP of Research & Chief Scientific Officer

Ms. Celia E. Eckert J.D.

Senior VP, General Counsel & Corporate Secretary

Mr. Charles Liles

Associate Director and Head of Corporate Communications & Investor Relations

Mr. Kirk Rosemark RAC

Senior Vice President of Regulatory Affairs & Quality Assurance

Mr. Eric P. Kowack

Senior Vice President of Program Leadership & Alliance Management

Dr. Mark Osterman M.D.

Senior Vice President of Clinical Development (Autoimmune)

Dr. Bassil I. Dahiyat Ph.D.

Co-Founder, CEO, President & Director

Mr. Bart Jan Cornelissen

Senior VP & CFO

FAQs

What is Xencor Inc share price today?

Xencor Inc share price today is $11.44 as on at the close of the market. Xencor Inc share today touched a day high of $12.4 and a low of $11.27.

What is the 52 week high and 52 week low for Xencor Inc share?

Xencor Inc share touched a 52 week high of $18.69 on and a 52 week low of $6.92 on . Xencor Inc stock price today i.e. is closed at $11.44,which is 38.79% down from its 52 week high and 65.32% up from its 52 week low.

What is Xencor Inc's market capitalisation today?

Xencor Inc market capitalisation is $0.00T as on .

How to invest in Xencor Inc Stock (XNCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xencor Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xencor Inc Shares that will get you 0.1311 shares as per Xencor Inc share price of $11.44 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Xencor Inc Stock (XNCR) from India?

Indian investors can start investing in Xencor Inc (XNCR) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Xencor Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Xencor Inc share’s latest price of $11.44 as on March 28, 2026 at 1:29 am IST, you will get 0.8741 shares of Xencor Inc. Learn more about fractional shares .

What are the returns that Xencor Inc has given to Indian investors in the last 5 years?

Xencor Inc stock has given -72.02% share price returns and 29.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?